IMMU-15. QUANTIFYING INTRATHECAL DRUG DELIVERY UTILIZING PROGRAMMABLE VENTRICULOPERITONEAL SHUNTS

BACKGROUND: Programmable ventriculoperitoneal (pVP) shunts are increasingly utilized for intraventricular chemotherapy, radioimmunotherapy, and/or cellular therapy. Shunt adjustments allow optimization of thecal space drug concentrations with minimization in the peritoneum. Drug delivery quantificat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: McThenia, Sheila, Pandit-Taskar, Neeta, Grkovski, Milan, Donzelli, Maria, Diagana, Safiatu, Greenfield, Jeffrey, Souweidane, Mark, Kramer, Kim
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Immunology/Immunotherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8168261/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noab090.122
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars